Nuance (NUAN +2.3%) valuation looks attractive , says UBS. With the healthcare business...


Nuance (NUAN +2.3%) valuation looks attractive , says UBS. With the healthcare business returning to double digit growth and mobile penetration accelerating, the firm says to look past the "market noise" and reiterates a buy on the shares. Separately, Craig Hallum ups the shares to Buy on valuation as well.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs